Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company (PG) files a wide range of documents with the U.S. Securities and Exchange Commission, providing detailed insight into its operations, capital structure, governance, and shareholder policies. As a New York Stock Exchange‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Exchange Act, P&G uses SEC filings to report material events, financing activities, executive and director matters, and shareholder meeting results.
Recent Form 8‑K filings illustrate the types of information investors can find. Regulation FD 8‑Ks document quarterly dividend declarations on common stock and ESOP convertible preferred stock, along with the company’s long record of consecutive dividend payments and increases. Other 8‑Ks report underwritten public offerings of U.S. dollar, euro, and pound sterling notes with various maturities, including floating rate notes and fixed‑rate notes issued under a shelf registration statement on Form S‑3, with related legal opinions filed as exhibits.
Additional 8‑Ks address governance topics such as the approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan, voting results from the Annual Meeting of Shareholders, and retirement announcements for senior executives. Earnings‑related 8‑Ks furnish quarterly results, slides used on earnings calls, and notices of webcasts. Together with the company’s proxy statement on Schedule 14A, these filings give a structured view of P&G’s executive compensation framework, board composition, and strategic priorities.
On this page, Stock Titan provides real‑time access to Procter & Gamble’s SEC filings as they appear on EDGAR, along with AI‑powered summaries to help explain the significance of each document. Users can quickly review annual and quarterly reports, current reports on Form 8‑K, and exhibits related to new debt offerings or compensation plans, as well as monitor items such as dividend announcements and shareholder vote outcomes without reading every page of the underlying filings.
Craig Arnold, a director of Procter & Gamble Co. (PG), was granted 189 restricted stock units (RSUs) on 09/09/2025. The award is under The Procter & Gamble 2019 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional RSUs. The filing reports 703.4862 shares (or RSU-equivalent) beneficially owned by the reporting person after the transaction. The Form 4 was signed by an attorney-in-fact on 09/10/2025 and discloses this non-derivative equity award.
Robert J. Portman, a director of Procter & Gamble Co. (PG), was granted 48 Restricted Stock Units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were recorded at a price of $0 and the reporting shows 3,419.5944 shares beneficially owned after the grant, a total that the filing states includes dividend equivalents credited as RSUs. The Form 4 was filed as a single-person filing and signed by an attorney-in-fact on 09/10/2025. The document contains only the listed grant details and explanatory footnotes.
Ashley McEvoy, a director of Procter & Gamble Co (PG), was awarded 189 shares of Common Stock on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The grant carries a $0 per-share transaction price and the total post-transaction beneficial ownership is reported as 3,843.0241 shares, which the filer says includes dividend equivalents issued as Restricted Stock Units. The Form 4 was signed by an attorney-in-fact on 09/10/2025. The filing discloses a routine equity award to a director as part of compensation; no sale or cash purchase occurred.
Christine M. McCarthy, a director of Procter & Gamble Co. (PG), reports a grant of 236 Restricted Stock Units (RSUs) on 09/09/2025 under the Procter & Gamble 2019 Stock & Incentive Compensation Plan. The RSUs were granted with a reported price of $0 and include dividend equivalents converted into additional RSUs. Following the grant, Ms. McCarthy beneficially owns 14,946.5131 shares (reported as direct ownership). The filing is signed by an attorney-in-fact on 09/10/2025 and includes the plan-based award disclosure in the explanatory notes.
Terry J. Lundgren, a director of Procter & Gamble (PG), was awarded 220 restricted stock units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a $0 per-share price as dividend-equivalent RSUs and are reported as 220 units added to his holdings. Following the transaction, Mr. Lundgren beneficially owns a total of 43,397.6912 shares, which includes RSU dividend equivalents and shares from the issuer's dividend reinvestment plan. Additionally, 530 shares are reported as indirectly held by his spouse.
Joseph Jimenez, a director of Procter & Gamble Co. (PG), was granted 298 restricted stock units (RSUs) on 09/09/2025. The award is reported as having a $0 per-share price because it is a restricted grant rather than an open-market purchase. After the grant (which includes dividend equivalents credited as RSUs), Mr. Jimenez beneficially owns 34,100.9784 shares in total. The RSUs were awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Jimenez on 09/10/2025.
The Vanguard Group reported ownership of 235,208,844 shares of Procter & Gamble (PG), representing 10.04% of the outstanding common stock. Vanguard discloses it is an investment adviser (IA) organized in Pennsylvania and holds 0 sole voting power, 13,404,221 shares with shared voting power, 212,819,403 shares with sole dispositive power, and 22,389,441 shares with shared dispositive power. The filing is a Schedule 13G/A amendment dated August 29, 2025, signed September 8, 2025.
Vanguard states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Procter & Gamble; the filing lists client accounts as the ultimate beneficial owners where applicable.
Susan Street Whaley, Chief Legal Officer & Secretary of Procter & Gamble (PG), reported a sale of 1,000 shares of P&G common stock on 08/29/2025 at $156.835 per share. After the sale she beneficially owned 28,435.8354 shares directly and 6,477.4515 shares indirectly via a retirement plan trustee. The Form 4 was executed by an attorney-in-fact.
The Procter & Gamble Company proxy statement describes board and governance practices, executive compensation design, and planned leadership transition. The Board comprises an independent majority and conducts annual director elections, regular executive sessions, and ongoing shareholder engagement including 75+ meetings in 2024-25. The compensation program emphasizes pay-for-performance with multi-year equity (PSPs, LTIP, RSUs), diversified performance metrics (organic sales growth, core EPS, operating profit, free cash flow) and a Relative TSR multiplier. The Compensation & Leadership Development Committee sets peer benchmarks, engages an independent consultant, enforces share ownership and clawback policies, and discloses that the 2024-25 Say-on-Pay received over 90% support. The filing notes a $1.0 billion after-tax impairment charge related to Gillette intangible assets and describes insider trading, related-person transaction, and equity plan provisions.
Form 144 notice for Procter & Gamble Company (PG) shows a proposed sale of 1,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $156,460. The filer reports acquiring 15,811 shares as a Performance Stock Program Award from Procter & Gamble and intends the sale approximately on 08/29/2025. The filing also discloses that the filer sold 6,167 shares for gross proceeds of $969,907.53. The notice includes the signed representation that the seller is unaware of undisclosed material adverse information about the issuer.